The harm caused by pelvic mesh and valproate represents some of the most serious patient safety failures in recent NHS history. Both caused avoidable, life-changing harm on a large scale, with patients not always receiving the right information to make informed decisions about their treatment, failures in post-market surveillance and patients’ concerns too often being dismissed. Valproate, while a vital treatment for some patients with epilepsy, migraine and bipolar disorder, can cause devastating harm to an unborn child when taken during pregnancy. The effects of prenatal exposure can be complex and lifelong, leaving many children, young people and adults unable…

I recently joined leaders from healthcare, technology, research and investment at the Milken Institute Asia Summit panel AI’s Health Care Promise: Getting It Right for Everyone. It was a timely discussion about how we can harness the benefits of artificial intelligence while ensuring it improves care for everyone, not just some.  One theme stood out: the question is no longer whether AI will play a role in healthcare. It already does, but the challenge is making sure it works safely, fairly and transparently for everyone.  That mirrors what we heard through the National Commission into the Regulation of AI in…